Trial of everolimus-eluting stents or bypass surgery for coronary disease

New England Journal of Medicine

Volumn 372, Issue 13, 2015, Pages 1204-1212

  Park, Seung Jung ^a   Ahn, Jung Min ^a   Kim, Young Hak ^a   Park, Duk Woo ^a   Yun, Sung Cheol ^b   Lee, Jong Young ^a   Kang, Soo Jin ^a   Lee, Seung Whan ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a   Choo, Suk Jung ^a   Chung, Cheol Hyun ^a   Lee, Jae Won ^a   Cohen, David J ^k   Yeung, Alan C ^l   Hur, Seung Ho ^g   Seung, Ki Bae ^c   Ahn, Tae Hoon ^h   Kwon, Hyuck Moon ^d   Lim, Do Sun ^e   Rha, Seung Woon ^f   Jeong, Myung Ho ⁱ   Lee, Bong Ki ^j   Tresukosol, Damras ^m   Fu, Guo Sheng ⁿ   Ong, Tiong Kiam ^o   more..

^a University of Ulsan   (South Korea)

^b Division of Biostatistics   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Korea University   (South Korea)

^f Korea University College of Medicine   (South Korea)

^g Dongsan Medical Center   (South Korea)

^h Gachon University   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Kangwon National University   (South Korea)

^k UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m MAHIDOL UNIVERSITY   (Thailand)

ⁿ ZHEJIANG UNIVERSITY   (China)

^o SARAWAK GENERAL HOSPITAL   (Malaysia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ADULT; AGED; ARTICLE; ASIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; EARLY TERMINATION OF CLINICAL TRIAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; RISK ASSESSMENT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; STROKE;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SIROLIMUS; STROKE;

EID: 84925427676     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1415447     Document Type: Article

References (25)

1. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72. [Erratum, N Engl J Med 2013;368:584.]
2. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-38.
3. Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J 2014;35:2821-30.
4. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-84.
5. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA 2013;310:2086-95.
6. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012;366:1467-76.
7. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med 2014;174:223-30.
8. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124(23):e652-e735.
9. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619.
10. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78.
11. Farooq V, Serruys PW, Zhang Y, et al. Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. J Am Coll Cardiol 2013;62:2360-9.
12. Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of fol-low- up from randomized trials. Circulation 2012;125:2873-91.
13. Gada H, Kirtane AJ, Newman W, et al. 5-Year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc Interv 2013;6:1263-6.
14. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011;364:1718-27.
15. Mercado N, Wijns W, Serruys PW, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005;130:512-9.
16. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
17. Cain KC, Lange NT. Approximate case influence for the proportional hazards regression model with censored data. Biometrics 1984;40:493-9.
18. Wiviott SD, Antman EM, Gibson CM, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J 2006;152:627-35.
19. Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation 2007;115:2352-7.
20. Smit Y, Vlayen J, Koppenaal H, et al. Percutaneous coronary intervention versus coronary artery bypass grafting: a metaanalysis. J Thorac Cardiovasc Surg 2014 November 1 (Epub ahead of print).
21. Misfeld M, Brereton RJ, Sweetman EA, Doig GS. Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: meta-analysis of 11,398 cases from 8 studies. J Thorac Cardiovasc Surg 2011;142(2):e11-e17.
22. Nasir K, Katz R, Takasu J, et al. Ethnic differences between extra-coronary measures on cardiac computed tomography: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2008;198:104-14.
23. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005;352:2174-83.
24. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:Suppl:I-200-I-206.
25. Stone GW, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxeleluting stents in coronary artery disease. N Engl J Med 2010;362:1663-74.